Frontiers in Cellular Neuroscience,
Год журнала:
2022,
Номер
16
Опубликована: Июнь 16, 2022
Chronic
cerebral
hypoperfusion
(CCH)
is
a
major
cause
of
vascular
cognitive
impairment
and
dementia
(VCID).
Although
the
underlying
mechanisms
have
not
been
fully
elucidated,
emerging
data
suggest
that
blood-brain
barrier
(BBB)
dysfunction
one
pivotal
pathological
changes
in
CCH.
BBB
appears
early
CCH,
contributing
to
deterioration
white
matter
development
impairment.
In
this
review,
we
summarize
latest
experimental
clinical
evidence
implicating
disruption
as
VCID.
We
discuss
focusing
on
cell
interactions
within
BBB,
well
potential
role
APOE
genotype.
summary,
provide
novel
insights
into
pathophysiological
benefits
therapeutic
interventions
targeting
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Июль 12, 2023
Abstract
Studies
in
neurodegenerative
diseases,
including
Alzheimer’s
disease,
Parkinson’s
disease
and
Amyotrophic
lateral
sclerosis,
Huntington’s
so
on,
have
suggested
that
inflammation
is
not
only
a
result
of
neurodegeneration
but
also
crucial
player
this
process.
Protein
aggregates
which
are
very
common
pathological
phenomenon
can
induce
neuroinflammation
further
aggravates
protein
aggregation
neurodegeneration.
Actually,
even
happens
earlier
than
aggregation.
Neuroinflammation
induced
by
genetic
variations
CNS
cells
or
peripheral
immune
may
deposition
some
susceptible
population.
Numerous
signaling
pathways
range
been
to
be
involved
the
pathogenesis
neurodegeneration,
although
they
still
far
from
being
completely
understood.
Due
limited
success
traditional
treatment
methods,
blocking
enhancing
inflammatory
considered
promising
strategies
for
therapy
many
them
got
exciting
results
animal
models
clinical
trials.
Some
them,
few,
approved
FDA
usage.
Here
we
comprehensively
review
factors
affecting
major
pathogenicity
sclerosis.
We
summarize
current
strategies,
both
clinic,
diseases.
Journal of Clinical Investigation,
Год журнала:
2022,
Номер
132(10)
Опубликована: Май 15, 2022
Alzheimer's
disease
and
related
dementias
(ADRD)
are
among
the
top
contributors
to
disability
mortality
in
later
life.
As
with
many
chronic
conditions,
aging
is
single
most
influential
factor
development
of
ADRD.
Even
older
adults
who
remain
free
dementia
throughout
their
lives,
cognitive
decline
neurodegenerative
changes
appreciable
advancing
age,
suggesting
shared
pathophysiological
mechanisms.
In
this
Review,
we
provide
an
overview
cognition,
brain
morphology,
neuropathological
protein
accumulation
across
lifespan
humans,
complementary
mechanistic
evidence
from
animal
models.
Next,
highlight
selected
processes
that
differentially
regulated
disease,
including
aberrant
autophagy,
mitochondrial
dysfunction,
cellular
senescence,
epigenetic
changes,
cerebrovascular
inflammation,
lipid
dysregulation.
We
summarize
research
clinical
translational
studies
link
biological
underlying
ADRD
pathogenesis.
Targeting
fundamental
may
represent
a
yet
relatively
unexplored
avenue
attenuate
both
age-related
Collaboration
fields
geroscience
neuroscience,
coupled
new
models
more
closely
align
human
processes,
necessary
advance
novel
therapeutic
discovery
realm.
Annual Review of Neuroscience,
Год журнала:
2023,
Номер
46(1), С. 101 - 121
Опубликована: Фев. 28, 2023
Astrocyte
endfeet
enwrap
the
entire
vascular
tree
within
central
nervous
system,
where
they
perform
important
functions
in
regulating
blood-brain
barrier
(BBB),
cerebral
blood
flow,
nutrient
uptake,
and
waste
clearance.
Accordingly,
astrocyte
contain
specialized
organelles
proteins,
including
local
protein
translation
machinery
highly
organized
scaffold
which
anchor
channels,
transporters,
receptors,
enzymes
critical
for
astrocyte-vascular
interactions.
Many
neurological
diseases
are
characterized
by
loss
of
polarization
specific
endfoot
dysregulation,
BBB
disruption,
altered
clearance,
or,
extreme
cases,
coverage.
A
role
has
been
demonstrated
or
postulated
many
these
conditions.
This
review
provides
an
overview
development,
composition,
function,
pathological
changes
highlights
gaps
our
knowledge
that
future
research
should
address.
Nature Aging,
Год журнала:
2024,
Номер
4(1), С. 33 - 47
Опубликована: Янв. 9, 2024
Abstract
Alzheimer’s
disease
(AD)
is
heterogenous
at
the
molecular
level.
Understanding
this
heterogeneity
critical
for
AD
drug
development.
Here
we
define
subtypes
using
mass
spectrometry
proteomics
in
cerebrospinal
fluid,
based
on
1,058
proteins,
with
different
levels
individuals
(
n
=
419)
compared
to
controls
187).
These
had
alterations
protein
that
were
associated
distinct
processes:
subtype
1
was
characterized
by
proteins
related
neuronal
hyperplasticity;
2
innate
immune
activation;
3
RNA
dysregulation;
4
choroid
plexus
dysfunction;
and
5
blood–brain
barrier
impairment.
Each
specific
genetic
risk
variants,
example,
enriched
TREM2
R47H.
Subtypes
also
differed
clinical
outcomes,
survival
times
anatomical
patterns
of
brain
atrophy.
results
indicate
highlight
need
personalized
medicine.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Март 12, 2024
Brain
perfusion
and
blood-brain
barrier
(BBB)
integrity
are
reduced
early
in
Alzheimer's
disease
(AD).
We
performed
single
nucleus
RNA
sequencing
of
vascular
cells
isolated
from
AD
non-diseased
control
brains
to
characterise
pathological
transcriptional
signatures
responsible
for
this.
show
that
endothelial
(EC)
enriched
expression
genes
associated
with
susceptibility
AD.
Increased
β-amyloid
is
BBB
impairment
a
dysfunctional
angiogenic
response
related
failure
increased
pro-angiogenic
HIF1A
VEGFA
signalling
EC.
This
inflammatory
activation,
EC
senescence
apoptosis.
Our
genomic
dissection
cell
risk
gene
enrichment
provides
evidence
role
pathology
suggests
reducing
activation
restoring
effective
angiogenesis
could
reduce
dysfunction
contributing
the
genesis
or
progression
Acta Neuropathologica,
Год журнала:
2024,
Номер
147(1)
Опубликована: Фев. 12, 2024
Abstract
Central
nervous
system
(CNS)
accumulation
of
fibrillary
deposits
made
Amyloid
β
(A
),
hyperphosphorylated
Tau
or
α
-synuclein
(
-syn),
present
either
alone
in
the
form
mixed
pathology,
characterizes
most
common
neurodegenerative
diseases
(NDDs)
as
well
aging
brain.
Compelling
evidence
supports
that
acute
neurological
disorders,
such
traumatic
brain
injury
(TBI)
and
stroke,
are
also
accompanied
by
increased
deposition
toxic
A
,
-syn
species.
While
contribution
these
pathological
proteins
to
neurodegeneration
has
been
experimentally
ascertained,
cellular
molecular
mechanisms
driving
-syn-related
damage
remain
be
fully
clarified.
In
last
few
years,
studies
have
shown
may
contribute
inducing
and/or
promoting
blood–brain
barrier
(BBB)
disruption.
These
can
affect
BBB
integrity
directly
affecting
key
components
pericytes
endothelial
cells
(ECs)
indirectly,
macrophages
activation
dysfunction.
Here,
we
summarize
critically
discuss
findings
showing
how
NDDs,
TBI
stroke.
We
highlight
need
for
a
deeper
characterization
role
dysfunction
macrophages,
ECs
improve
diagnosis
treatment
chronic
disorders.
Journal of Advanced Research,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
Endothelial
cells
(ECs)
and
pericytes
(PCs)
are
crucial
components
of
the
vascular
system,
with
ECs
lining
inner
layer
blood
vessels
PCs
surrounding
capillaries
to
regulate
flow
angiogenesis.
Intercellular
communication
between
is
vital
for
formation,
stability,
function
vessels.
Various
signaling
pathways,
such
as
endothelial
growth
factor/vascular
factor
receptor
pathway
platelet-derived
factor-B/platelet-derived
receptor-β
pathway,
play
roles
in
PCs.
Dysfunctional
these
associated
various
diseases,
including
central
nervous
system
disorders,
certain
types
cancers.
review:
This
review
aimed
explore
diverse
formation
reshaping
focused
on
essential
pathways
that
facilitate
investigated
how
disruptions
may
contribute
disease.
Additionally,
explored
potential
therapeutic
targets,
future
research
directions,
innovative
approaches,
investigating
impact
EC-PCs
novel
systemic
addressing
resistance
antiangiogenic
drugs,
developing
medications
enhance
efficacy.
Key
scientific
concepts
Disordered
EC-PC
intercellular
plays
a
role
abnormal
vessel
thus
contributing
progression
diseases
development
drugs.
Therefore,
studies
interactions
have
high
clinical
relevance.
Frontiers in Aging Neuroscience,
Год журнала:
2022,
Номер
14
Опубликована: Апрель 25, 2022
For
decades,
it
has
been
widely
believed
that
the
blood–brain
barrier
(BBB)
provides
an
immune
privileged
environment
in
central
nervous
system
(CNS)
by
blocking
peripheral
cells
and
humoral
factors.
This
view
revised
recent
years,
with
increasing
evidence
revealing
plays
a
critical
role
regulating
CNS
homeostasis
disease.
Neurodegenerative
diseases
are
characterized
progressive
dysfunction
loss
of
neurons
CNS.
An
number
studies
have
focused
on
connection
between
neurodegenerative
diseases.
On
one
hand,
peripherally
released
cytokines
can
cross
BBB,
cause
direct
neurotoxicity
contribute
to
activation
microglia
astrocytes.
other
also
infiltrate
brain
participate
progression
neuroinflammatory
high
morbidity
disability
rate,
yet
there
no
effective
therapies
stop
or
reverse
their
progression.
In
neuroinflammation
received
much
attention
as
therapeutic
target
for
many
this
review,
we
highlight
emerging
systems
diseases,
well
interactions.
A
better
understanding
may
improve
strategies
Cells,
Год журнала:
2023,
Номер
12(15), С. 1931 - 1931
Опубликована: Июль 26, 2023
Pericytes
are
specialized
cells
located
in
close
proximity
to
endothelial
within
the
microvasculature.
They
play
a
crucial
role
regulating
blood
flow,
stabilizing
vessel
walls,
and
maintaining
integrity
of
blood–brain
barrier.
The
loss
pericytes
has
been
associated
with
development
progression
various
diseases,
such
as
diabetes,
Alzheimer’s
disease,
sepsis,
stroke,
traumatic
brain
injury.
This
review
examines
detection
pericyte
different
explores
methods
employed
assess
coverage,
elucidates
potential
mechanisms
contributing
these
pathological
conditions.
Additionally,
current
therapeutic
strategies
targeting
discussed,
along
future
interventions
aimed
at
preserving
function
promoting
disease
mitigation.